Company Description
Manhattan Scientifics (OTC Link: MHTX) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $55.9K.
MHTX stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of MHTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Manhattan Scientifics (MHTX) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $55.9K, MHTX is classified as a micro-cap stock with approximately 559.3M shares outstanding.
Latest News
Manhattan Scientifics has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include clinical trial. View all MHTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Manhattan Scientifics (MHTX) currently stands at 20.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Manhattan Scientifics (MHTX) currently stands at 1.0 days, down 85% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
MHTX Company Profile & Sector Positioning
Manhattan Scientifics (MHTX) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MHTX often look at related companies in the same sector, including Acutus Medical, Inc. (AFIB), TRANSLATE BIO, INC. (TBIO), Nemaura Med Inc (NMRD), Sonendo Inc (SONX), and Fuse Medical (FZMD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MHTX's relative position within its industry.